CCDC117
-
Official Full Name
coiled-coil domain containing 117 -
Synonyms
CCDC117;coiled-coil domain containing 117;coiled-coil domain-containing protein 117;FLJ33814;dJ366L4.1
Recombinant Proteins
- Human
- Rat
- Mouse
- Wheat Germ
- Mammalian Cell
- HEK293
- HEK293T
- In Vitro Cell Free System
- GST
- His
- Non
- His&Fc&Avi
- Myc&DDK
Involved Pathway
CCDC117 involved in several pathways and played different roles in them. We selected most pathways CCDC117 participated on our site, such as , which may be useful for your reference. Also, other proteins which involved in the same pathway with CCDC117 were listed below. Creative BioMart supplied nearly all the proteins listed, you can search them on our site.
| Pathway Name | Pathway Related Protein |
|---|
Protein Function
CCDC117 has several biochemical functions, for example, protein binding. Some of the functions are cooperated with other proteins, some of the functions could acted by CCDC117 itself. We selected most functions CCDC117 had, and list some proteins which have the same functions with CCDC117. You can find most of the proteins on our site.
| Function | Related Protein |
|---|---|
| protein binding | INO80,SSSCA1,NEK2,SUMO2,EMID2,TFAP2C,SNAPC3,MUTYH,RNF19B,HSPD1 |
Interacting Protein
CCDC117 has direct interactions with proteins and molecules. Those interactions were detected by several methods such as yeast two hybrid, co-IP, pull-down and so on. We selected proteins and molecules interacted with CCDC117 here. Most of them are supplied by our site. Hope this information will be useful for your research of CCDC117.
HSP90AA1;STIP1;b3ktt5_human;q53fc7_human;HSP90AB1;q96be0_human;HSP90AB1
Resources
Related Services
Related Products
References
- Zeng, Y; Xiang, JS; et al. sghC1q, a novel C1q family member from half-smooth tongue sole (Cynoglossus semilaevis): Identification, expression and analysis of antibacterial and antiviral activities. DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY 48:151-163(2015).
- Miller, GD; Woessner, DW; et al. Multidomain Targeting of Bcr-Abl by Disruption of Oligomerization and Tyrosine Kinase Inhibition: Toward Eradication of CML. MOLECULAR PHARMACEUTICS 10:3475-3483(2013).
